Home › Sakit ni Parkinson › Washington
Pag-aaral pangklinika para sa Sakit ni Parkinson sa Washington
15 pag-aaral para sa Sakit ni Parkinson ang naghahanap ng mga kalahok sa mga site sa Washington.
Mga Lungsod sa Washington
Opisyal na teksto ng pag-aaral (English)
SAD Study in Patients With Parkinson's Disease and Motor Fluctuations
- Inland Northwest Research, Spokane
Nagre-recruitPhase 1
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07422675Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
- Evergreen Health, Kirkland
- Virginia Mason Medical Center, Seattle
- University of Washington Medical Center, Seattle
- at 1 pa
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT02071134A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #023, Kirkland
- Vima Site #015, Spokane
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07804615A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- EvergreenHealth - Research Department, Kirkland
Nagre-recruitPhase 3
Edad 45 hanggang 75 · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT06944522A Study of Buntanetap in Participants With PD
- Inland Northwest Research, Spokane
Nagre-recruitPhase 2/3
Edad 40 hanggang 85 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07284784A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- EvergreenHealth, Kirkland
- Inland Northwest Research, Spokane
Nagre-recruitPhase 2
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06680830A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- EvergreenHealth (Site #219), Kirkland
Nagre-recruitPhase 2
Edad 30 hanggang 80 · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT07432958A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Site-007, Bellevue
- Site-019, Seattle
Nagre-recruitPhase 2/3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Okt 22, 2026 · NCT06976268A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
- Evergreen Health Research, Kirkland
- Inland Northwest Research, Spokane
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 30 hanggang 85 · Lahat ng kasarian · Na-update Okt 14, 2026 · NCT06809400Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
- Inland Northwest Research, Spokane
Nagre-recruitPhase 2
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07005180Parkinson's Foundation PD GENEration Genetic Registry
- Evergreen Health, Kirkland
- Inland Northwest Research, Spokane
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT04994015A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
- VA Puget Sound Health Care System, Seattle
Nagre-recruitObservasyonal na pag-aaral
Edad 45 hanggang 75 · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07330258PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- Univ of Washington and VA Puget Sound Health Care System, Seattle
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 30 pataas · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT04477785Use of CereGate Therapy for Freezing of Gait in PD
- University of Washington, Seattle
Nagre-recruit
Edad 21 hanggang 80 · Lahat ng kasarian · Na-update May 28, 2026 · NCT05292794Modifiable Variables in Parkinsonism (MVP)
- Bastyr University, Kenmore
Nagre-recruitObservasyonal na pag-aaral
Edad 19 pataas · Lahat ng kasarian · Na-update Mar 25, 2022 · NCT02194816Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.